U.S. flag

An official website of the United States government

NM_014874.4(MFN2):c.310C>T (p.Arg104Trp) AND Hereditary motor and sensory neuropathy with optic atrophy

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Sep 4, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000002370.7

Allele description [Variation Report for NM_014874.4(MFN2):c.310C>T (p.Arg104Trp)]

NM_014874.4(MFN2):c.310C>T (p.Arg104Trp)

Gene:
MFN2:mitofusin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.22
Genomic location:
Preferred name:
NM_014874.4(MFN2):c.310C>T (p.Arg104Trp)
Other names:
p.R104W:CGG>TGG; chr1-11992689-C-T; p.Arg104Trp
HGVS:
  • NC_000001.11:g.11992689C>T
  • NG_007945.1:g.17509C>T
  • NM_001127660.2:c.310C>T
  • NM_014874.4:c.310C>TMANE SELECT
  • NP_001121132.1:p.Arg104Trp
  • NP_001121132.1:p.Arg104Trp
  • NP_055689.1:p.Arg104Trp
  • NP_055689.1:p.Arg104Trp
  • LRG_255t1:c.310C>T
  • LRG_255:g.17509C>T
  • LRG_255p1:p.Arg104Trp
  • NC_000001.10:g.12052746C>T
  • NM_001127660.1:c.310C>T
  • NM_014874.3:c.310C>T
Protein change:
R104W; ARG104TRP
Links:
OMIM: 608507.0014; dbSNP: rs119103268
NCBI 1000 Genomes Browser:
rs119103268
Molecular consequence:
  • NM_001127660.2:c.310C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_014874.4:c.310C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary motor and sensory neuropathy with optic atrophy
Synonyms:
CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; PERIPHERAL NEUROPATHY AND OPTIC ATROPHY
Identifiers:
MONDO: MONDO:0019551; MedGen: C0393807

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000022528OMIM
no assertion criteria provided
Pathogenic
(Dec 9, 2008)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001367007Centre for Mendelian Genomics, University Medical Centre Ljubljana
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Sep 4, 2019)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction.

Del Bo R, Moggio M, Rango M, Bonato S, D'Angelo MG, Ghezzi S, Airoldi G, Bassi MT, Guglieri M, Napoli L, Lamperti C, Corti S, Federico A, Bresolin N, Comi GP.

Neurology. 2008 Dec 9;71(24):1959-66. doi: 10.1212/01.wnl.0000327095.32005.a4. Epub 2008 Oct 22.

PubMed [citation]
PMID:
18946002

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000022528.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In an Italian father and 2 sons with peripheral neuropathy, Del Bo et al. (2008) identified a heterozygous c.310C-T transition in exon 4 of the MFN2 gene, resulting in an arg104-to-trp (R104W) substitution at a highly conserved residue in the GTPase domain. The phenotype was highly variable within the family. The father had a symmetric axonal, predominantly motor polyneuropathy, spastic gait, and pes cavus, consistent with Charcot-Marie-Tooth disease-2A2A (CMT2A2A; 609260), as well as impaired nocturnal vision and sensorineural hearing loss, consistent with hereditary motor and sensory neuropathy type VIA (HMSN6A; 601152). He also showed cognitive decline first noted in his forties. Both sons had delayed motor and language development, decreased IQ, steppage gait, distal muscle weakness and atrophy, and axonal sensorimotor neuropathy at ages 10 and 7 years, respectively. One son also had optic nerve dysfunction. MR spectroscopy (MRS) in the father suggested a defect in mitochondrial energy metabolism in the occipital cortex. Del Bo et al. (2008) suggested that central nervous system involvement and cognitive impairment may be other phenotypic features of MFN2 mutations.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Centre for Mendelian Genomics, University Medical Centre Ljubljana, SCV001367007.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM1,PM2,PM5,PP3.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024